1 | Study | 1.63% | |
2 | Cancer | 1.24% | |
3 | Health | 1.13% | |
4 | New | 1.13% | |
5 | Brain | 0.9% | |
6 | Treatment | 0.9% | |
7 | Disease | 0.85% | |
8 | Risk | 0.85% | |
9 | May | 0.79% | |
10 | Heart | 0.73% | |
11 | Research | 0.68% | |
12 | Women | 0.56% | |
13 | Childhood | 0.45% | |
14 | Australia | 0.45% | |
15 | News | 0.45% | |
16 | Cells | 0.39% | |
17 | Gene | 0.39% | |
18 | Therapy | 0.39% | |
19 | Patients | 0.34% | |
20 | Bacteria | 0.34% | |
21 | Day | 0.34% | |
22 | Could | 0.34% | |
23 | Rare | 0.34% | |
24 | Global | 0.34% | |
25 | COVID-19 | 0.34% | |
26 | Genetic | 0.34% | |
27 | Boost | 0.28% | |
28 | COVID | 0.28% | |
29 | Severe | 0.28% | |
30 | Key | 0.28% | |
31 | High | 0.28% | |
32 | Alzheimers | 0.28% | |
33 | Drug | 0.28% | |
34 | Tumors | 0.28% | |
35 | MS | 0.28% | |
36 | Drugs | 0.28% | |
37 | Dementia | 0.28% | |
38 | Ozempic | 0.28% | |
39 | Link | 0.28% | |
40 | National | 0.28% | |
41 | HIV | 0.28% | |
42 | Covid | 0.28% | |
43 | Early | 0.28% | |
44 | NSW | 0.28% | |
45 | RSV | 0.23% | |
46 | Care | 0.23% | |
47 | Virus | 0.23% | |
48 | Than | 0.23% | |
49 | Liver | 0.23% | |
50 | Long | 0.23% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
'Cause for optimism': Most long COVID patients have immunological recovery in two years
Australian Doctor
2024-04-24 12:50:18
Are Monoclonal Antibodies the Future of Long COVID Treatments?
Technology Networks
2024-04-24 00:02:12
Department of Health
2024-04-23 12:39:03
Evaluating the Effectiveness of Monovalent COVID-19 Vaccines in Children and Adolescents
Contagionlive.com
2024-04-22 21:31:31
Aging affects immune response and virus dynamics in COVID-19 patients, study finds - News
Medical.Net
2024-04-19 12:35:00
Longest Chronic Covid Case Spurs Fear of New Immune-Evasive Variants
Mirage News
2024-04-19 07:08:00